Q3 biotech roundup: The 2024 turnaround sputters into a critical Q4 finale

Some, though certainly not all, chief indicators of biotech business activity are pointed shakily north as we head into a critical Q4. But biotech shows …

This article is available only to Premium subscribers

Upgrade to Premium for unlimited access and Premium exclusives.

Updated: ‘Ruthless’ pipeline prioritization, obesity and China: Three takeaways from AstraZeneca’s Q4

LONDON — AstraZeneca on Thursday morning teased its vision on how it could potentially enter the obesity market, as well as its views on further

February 9, 2024

TRYP THERAPEUTICS PROVIDES UPDATE ON PLAN OF ARRANGEMENT WITH EXOPHARM LIMITED AND ANNOUNCES VOLUNTARY TRADING HALT – Biotech Investments

, 04/24/2024 / 06:00, EST/EDT – EQS Newswire – Tryp Therapeutics Inc. (Regulated Unofficial Market in Berlin, Frankfurt, Munich, Stuttgart, Tradegate Exchange; Canadian Stock Exchange,

April 25, 2024

The case against age limits for politicians

A recent poll from YouGov/CBS News showed that 77% of respondents said that there should be a maximum age limit for elected officials, with the

October 4, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.